FDA’s Prasad Exits Following Political Backlash Over Sarepta

Vinay Prasad, a top regulator at the US Food and Drug Administration, left the agency after a short-lived tenure that ended after political backlash from conservative pundits over his handling of Sarepta Therapeutics Inc.’s gene therapy.